Cell Biology
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tumor necrosis factor ligand superfamily member 11(TNFSF11) | Login | Tumor necrosis factor ligand superfamily member 11(TNFSF11) | ||||||||||||||||
|
||||||||||||||||||
| Tumor necrosis factor receptor superfamily member 19L(Relt) | Login | Tumor necrosis factor receptor superfamily member 19L(Relt) | ||||||||||||||||
|
||||||||||||||||||
| Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173) | Login | Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173) | ||||||||||||||||
|
||||||||||||||||||
| Vimentin Protein (VIM) | Login | Vimentin Protein (VIM) | ||||||||||||||||
|
||||||||||||||||||
| Epidermal growth factor receptor(EGFR) | Login | Epidermal growth factor receptor(EGFR) | ||||||||||||||||
|
||||||||||||||||||
| Fibroblast growth factor 21(FGF21)(29-210) | Login | Fibroblast growth factor 21(FGF21)(29-210) | ||||||||||||||||
|
||||||||||||||||||
| Interleukin-2 receptor subunit alpha(IL2RA) | Login | Interleukin-2 receptor subunit alpha(IL2RA) | ||||||||||||||||
|
||||||||||||||||||
| Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | Login | Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | Login | Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | Login | Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | Login | Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | Login | Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | Login | Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | Login | Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | Login | Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | Login | Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | Login | Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | Login | Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | Login | Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | Login | Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | Login | Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Fremanezumab Biosimilar - Anti-CALCA , CALCB mAb - Research Grade | Login | Fremanezumab Biosimilar - Anti-CALCA , CALCB mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Fremanezumab Biosimilar - Anti-CALCA , CALCB mAb - Research Grade | Login | Fremanezumab Biosimilar - Anti-CALCA , CALCB mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||


